Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Feb 6, 2020
Date Accepted: Jun 28, 2020

The final, peer-reviewed published version of this preprint can be found here:

How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data

Kaleta M, Niederkrotenthaler T, Kautzky-Willer A, Klimek P

How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data

JMIR Med Inform 2020;8(9):e18147

DOI: 10.2196/18147

PMID: 32936077

PMCID: 7527915

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

How Specialist Aftercare Impacts on Long-Term Readmission Risks in Elderly Patients with Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data

  • Michaela Kaleta; 
  • Thomas Niederkrotenthaler; 
  • Alexandra Kautzky-Willer; 
  • Peter Klimek

ABSTRACT

Background:

The health state of elderly patients is typically characterized by multiple cooccurring diseases requiring the involvement of several types of healthcare provider.

Objective:

We aim to quantify how multimorbid patients benefit from seeking specialist care in terms of long-term readmission risks.

Methods:

From an administrative database we identify 225,238 elderly patients with 97 different diagnosis (ICD10 codes) from hospital stays and contacts with 13 medical specialties. For each diagnosis associated with the first hospital stay, we use multiple logistic regression to quantify the sex-specific and age-adjusted long-term all cause readmission risk (hospitalizations occurring between 3 months and 3 years after the first admission) and how specialist contacts impact on these risks.

Results:

Males have higher readmission risks than females (mean difference over all first diagnoses 1.9%, p<.001), but similar readmission risk reductions after receiving specialist care. Specialist care can reduce readmission risks by almost 50%. We find the greatest risk reductions when the first hospital stay was associated with diagnoses corresponding to complex chronic diseases such as acute myocardial infarction (reduced readmission risk of 57.6% SE 7.6% for males [m], females [f]: 55.9% SE 9.8%), diabetic and other retinopathies (m: 62.3% SE 8.0, f: 60.1% SE 8.4%), chronic obstructive pulmonary disease (m: 63.9% SE 7.8%, f: 58.1% SE 7.5%), disorders of lipoprotein metabolism (m: 64.7% SE 3.7%, f: 63.8% SE 4.0%) and chronic ischemic heart diseases (m: 63.6% SE 3.1%, f: 65.4% SE 3.0%).

Conclusions:

Specialist care can greatly reduce long-term readmission risks for chronic and multimorbid patients. Further research is needed to identify the specific reasons of these findings, and to understand the sex-specific biases detected.


 Citation

Please cite as:

Kaleta M, Niederkrotenthaler T, Kautzky-Willer A, Klimek P

How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data

JMIR Med Inform 2020;8(9):e18147

DOI: 10.2196/18147

PMID: 32936077

PMCID: 7527915

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.